The next key information is a Notice to obtain shareholder approval to the sale of the Orthopedic Division with the target date for the meeting being 31 July which would require the Notice to be issued next week. AMT has stated that FDA approval is now not expected until near Xmas.
Ann: AMT Submits 510(k) for Spinal Cage FDA Clearance, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AMT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.468M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AMT (ASX) Chart |
Day chart unavailable